Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07796152 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Suzetrigine vs. Standard Care Pain Relief Following Outpatient Knee Replacement Surgery

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Endeavor Health

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified
    • Interventions modified
    • Study description shortened, about 2 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research is to see if a person having an outpatient total knee replacement will have a difference in their pain and the amount of pain medication (opioids) used after discharge if they are given suzetrigine (a non-opioid pain medicine, also known as Journavx®) in addition to the standard pain medicines usually prescribed. Participants will complete a daily pain and medication diary and survey for up to 14 days post-operatively and on day 30.
Trial Details
NCT Number NCT07796152
Lead Sponsor Endeavor Health
Conditions
(from sponsor)		 Knee Arthroplasty, Total, Post Operative Pain, Acute, Opioid Consumption, Postoperative
Related terms Postoperative Pain
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov